The Chemours Company has confirmed to H2 View that it has put a $200m expansion of its fuel cell and electrolyser membrane manufacturing on hold as part of its reduction in hydrogen investments.

In its Q3 2024 results, the DuPont spin-off said a recent review of “third-party industry projections” now reflects “lower-end market demand” as well as “slower market growth through 2030” for hydrogen, with a “more uncertain growth trajectory” in the long-term.

This is a paid article, to read the article in full you can
sign in if you are subscribed or
subscribe today.